Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

Richard Brasington Jr., MD, FACP, MACR  |  Issue: November 2022  |  November 4, 2022

I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and avoid another mishap.

We should apply the same process to medical practices that were once considered good medical practice, but later were deemed undesirable. The liberal prescribing of high-dose chronic opioids is a good example.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

When I began medical school in 1976, many things we now take for granted did not yet exist: computerized tomography and magnetic resonance imaging scans, effective medications for peptic ulcer disease and viral hepatitis, laparoscopic surgery, monoclonal antibody therapies, third-generation cephalosporins, the diagnosis of human immunodeficiency virus and its therapies, and on and on.

The chronic administration of opioid pain relievers would also be on that list. In the fullness of time, we have all realized that prescribing opioids over the long term in high doses for chronic pain was a bad idea. I have given a lot of thought to the question of how We—the medical profession and society in general—could have gotten this so wrong.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Blaming pharmaceutical companies for what happened is very much in vogue, and no doubt they deserve some of that opprobrium. However, in my view, that is a vast oversimplification of what happened. Although I recognize that physicians are unconsciously influenced by the pharmaceutical industry, I believe those of us who prescribed chronic opioids did so because we thought we were acting in the best interests of our patients.

A Complicated Situation

What follows is my personal recollection of how this complicated situation evolved over several decades. I think it is critical that those trained in the past 10 years or so understand how this story unfolded: “What were they thinking?”

Before and during medical school, I understood that administration of opioids for short courses was appropriate for post-surgical pain or trauma. As a teen, I had several painful kidney surgeries and learned that a shot of meperidine could dramatically relieve severe pain within a few minutes.

My first encounter with chronic use by a patient was in the fall of 1980, during my medical internship. A slight, elderly lady with advanced multiple myeloma was hospitalized under my care; her oncologist had prescribed methadone for severe bone pain. One morning when we could not awaken her, we realized that her methadone levels had accumulated to toxic levels. After we administered naloxone, she woke up, and this sweet little old lady briefly became a raving maniac.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:AnalgesicsDrug UpdatesOpinionSpeak Out Rheum Tagged with:opioid crisisPain Syndrome FocusRheumSpeak Out Rheumatology

Related Articles
    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

    10 Tips for Opioid Prescribing

    December 1, 2014

    How to manage the risks when prescribing medications for patients in chronic pain

    Beyond Addiction: Medical Therapy for Addiction May Benefit Medical Adherence

    June 17, 2019

    Treating patients with rheumatic disease for their addictions will also encourage patients to address their overall health conditions, resulting in better medical adherence…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences